Form 4: Guardant Health CFO Executes Stock Sale

Guardant Health Chief Financial Officer Michael Brian Bell sold 2,000 shares of common stock on June 5, 2026.

Summary

• Michael Brian Bell, Chief Financial Officer of Guardant Health, Inc., sold 2,000 shares of common stock.
• The shares were sold at a weighted average price of $128.6203 per share.
• The transaction occurred on June 5, 2026.
• Following this transaction, the reporting person retains beneficial ownership of 47,509 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale appears to be a routine financial management action by an executive.

Positives

• The transaction represents a routine divestment rather than a complete liquidation of holdings.

Negatives

• Insider selling can sometimes be perceived by the market as a lack of confidence in near-term price appreciation.

Risks

• Market volatility affecting the share price of Guardant Health.

Future Outlook

No forward-looking guidance or strategic outlook was provided in this regulatory filing.

Industry Context

StockSavvy.ai notes that insider selling by C-suite executives is a common occurrence for liquidity or tax planning purposes and does not necessarily indicate a change in company fundamentals.

Comparison to Industry Standards

• Insider transactions are standard regulatory disclosures for publicly traded biotechnology and healthcare companies.
• The volume of shares sold is relatively small compared to the total holdings of the executive.

Stakeholder Impact

• Minimal impact expected on shareholders as the transaction size is limited.

Key Dates

Keywords

Guardant Health, GH, Insider Trading, Form 4, CFO, Stock Sale